Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pilch

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
International Journal of Oncology|November 20, 2001
Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinomaU Ritz, F Momburg, H Pilch, et al.
Journal of the National Cancer Institute|July 1, 1976
Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNAD H Kern, D Fritze, P M Schick, et al.
Zentralblatt Fur Gynakologie|April 21, 1999
[Value of clinically established MRI procedures concerning the pretherapeutic evaluation of maximal tumor diameter in primary or recurrent cervix cancer in relation to palpation findings and histopathologic whole mount specimens]U Schäffer, H Hawighorst, H Pilch, et al.
International Journal of Cancer|January 15, 1976
Detection of private and common tumor-associated antigens in murine sarcomas induced by different chemical carcinogensD Fritze, D H Kern, J A Humme, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1975
Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. I. Hematologic and immunologic parameters in vivoS R Waldman, J A Roth, M Silverstein, et al.
Annals of Internal Medicine|July 1, 1975
Current and future concepts of lung cancerJ R Benfield, G J Julliard, Y H Pilch, et al.
Journal of the National Cancer Institute|January 1, 1977
Specificity of antitumor immune reactions mediated by xenogeneic immune RNAD H Kern, C R Drogemuller, N Chow, et al.
Zentralblatt Fur Gynakologie|March 26, 2003
CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7H Pilch, H Hoehn, M Schmidt, et al.
International Journal of Cancer|January 15, 1982
Immunotherapy of a murine colon cancer with syngeneic spleen cells, immune RNA and tumor antigenM Fukushima, M E Colmerauer, S K Nayak, et al.
Gynecologic Oncology|June 15, 1999
Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parametersH Pilch, U Schäffer, K Schlenger, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Oncology|November 20, 2001
Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinomaU Ritz, F Momburg, H Pilch, et al.
Journal of the National Cancer Institute|July 1, 1976
Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNAD H Kern, D Fritze, P M Schick, et al.
Zentralblatt Fur Gynakologie|April 21, 1999
[Value of clinically established MRI procedures concerning the pretherapeutic evaluation of maximal tumor diameter in primary or recurrent cervix cancer in relation to palpation findings and histopathologic whole mount specimens]U Schäffer, H Hawighorst, H Pilch, et al.
International Journal of Cancer|January 15, 1976
Detection of private and common tumor-associated antigens in murine sarcomas induced by different chemical carcinogensD Fritze, D H Kern, J A Humme, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1975
Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. I. Hematologic and immunologic parameters in vivoS R Waldman, J A Roth, M Silverstein, et al.
Annals of Internal Medicine|July 1, 1975
Current and future concepts of lung cancerJ R Benfield, G J Julliard, Y H Pilch, et al.
Journal of the National Cancer Institute|January 1, 1977
Specificity of antitumor immune reactions mediated by xenogeneic immune RNAD H Kern, C R Drogemuller, N Chow, et al.
Zentralblatt Fur Gynakologie|March 26, 2003
CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7H Pilch, H Hoehn, M Schmidt, et al.
International Journal of Cancer|January 15, 1982
Immunotherapy of a murine colon cancer with syngeneic spleen cells, immune RNA and tumor antigenM Fukushima, M E Colmerauer, S K Nayak, et al.
Gynecologic Oncology|June 15, 1999
Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parametersH Pilch, U Schäffer, K Schlenger, et al.
Pageof 7